A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program ...

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

The global CRISPR gene editing market size is calculated at USD 4.77 billion in 2025 and is expected to reach around USD ...

CRISPR Therapeutics (NasdaqGM:CRSP) witnessed a substantial price movement, increasing 57% over the last quarter. This significant rise aligns with key developments, such as the company's inclusion in ...

Names including Kohls, Plug Power, and Mara Holdings round out the list of the market's top 10 most-shorted stocks.

CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and ...

New research has found a novel target with therapeutic potential for metastatic eye melanoma—an aggressive eye cancer—with ...

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.

KJ Muldoon recently made history by becoming the first patient to receive a personalized CRISPR gene therapy, designed specifically for the genetic mutations causing his rare metabolic disease. | KJ ...

Scientists have created a near-copy of the long-extinct dire wolf. Using advanced CRISPR gene editing tech, it now looks ...

Martin Kampmann, PhD, delivers the 2025 Byers Lecture. Photo by Sonya YruelWhen Martin Kampmann, PhD, set out to explore the ...